The effectiveness and value of sotatercept for pulmonary arterial hypertension: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council.

Authors :: Nikitin D
Lin GA
Whittington MD
Nhan E
Kayali Y
Rind DM
Pearson SD
Agboola F
Source :: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 May; Vol. 30 (5), pp. 491-495.
Publication Year :: 2024

Subjects :: Humans
Cost-Benefit Analysis
Treatment Outcome
Comparative Effectiveness Research
United States
Antihypertensive Agents economics
Antihypertensive Agents therapeutic use
Advisory Committees
Pulmonary Arterial Hypertension drug therapy
Pulmonary Arterial Hypertension economics

Full Text Access

Tools